Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.05), versus $0.01 reported last year. Revenue for the quarter came in at $9 million, versus $7.89 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.